These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21228496)

  • 21. M30 does not predict the severity of hepatosteatosis, whereas adiponectin level declined with increase of ALT and the severity of hepatic steatosis.
    Caner S; Altınbaş A; Saykı M; Büyükcam F; Yılmaz B; Çakal E; Çoban Ş; Delibaşı T
    J Clin Lab Anal; 2014 Sep; 28(5):381-5. PubMed ID: 24648300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum C1q/TNF-related protein 9 is not related to nonalcoholic fatty liver disease.
    Zhang C; Zhou N; Qiu P; Fu Y; Liu Z; Li H; Yang X; Zhang L
    Cytokine; 2018 Oct; 110():52-57. PubMed ID: 29704818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An initial evaluation of newly proposed biomarker of zinc status in humans - linoleic acid: dihomo-γ-linolenic acid (LA:DGLA) ratio.
    Knez M; Stangoulis JCR; Zec M; Debeljak-Martacic J; Pavlovic Z; Gurinovic M; Glibetic M
    Clin Nutr ESPEN; 2016 Oct; 15():85-92. PubMed ID: 28531790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease.
    Maliken BD; Nelson JE; Klintworth HM; Beauchamp M; Yeh MM; Kowdley KV
    Hepatology; 2013 May; 57(5):1806-13. PubMed ID: 23325576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan.
    Okushin K; Takahashi Y; Yamamichi N; Shimamoto T; Enooku K; Fujinaga H; Tsutsumi T; Shintani Y; Sakaguchi Y; Ono S; Kodashima S; Fujishiro M; Moriya K; Yotsuyanagi H; Mitsushima T; Koike K
    BMC Gastroenterol; 2015 Feb; 15():25. PubMed ID: 25880912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease.
    Wu G; Li H; Fang Q; Zhang J; Zhang M; Zhang L; Wu L; Hou X; Lu J; Bao Y; Jia W
    Sci Rep; 2017 Jul; 7(1):5095. PubMed ID: 28698650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents.
    Fu CC; Chen MC; Li YM; Liu TT; Wang LY
    Ann Acad Med Singap; 2009 Jan; 38(1):15-7. PubMed ID: 19221666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation: a case-control study on Asian Indians in North India.
    Nigam P; Bhatt SP; Misra A; Vaidya M; Dasgupta J; Chadha DS
    PLoS One; 2013; 8(1):e49286. PubMed ID: 23326306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].
    Zhang DM; Zhang GY; Wang T; Zhong HJ; Chen WK
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1279-83. PubMed ID: 16796890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver disease.
    Mueller S; Nahon P; Rausch V; Peccerella T; Silva I; Yagmur E; Straub BK; Lackner C; Seitz HK; Rufat P; Sutton A; Bantel H; Longerich T
    Hepatology; 2017 Jul; 66(1):96-107. PubMed ID: 28170108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum retinol binding protein 4 is negatively related to beta cell function in Chinese women with non-alcoholic fatty liver disease: a cross-sectional study.
    Yan H; Chang X; Xia M; Bian H; Zhang L; Lin H; Chen G; Zeng M; Gao X
    Lipids Health Dis; 2013 Oct; 12():157. PubMed ID: 24160775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between serum cytokeratin 18 and N-terminal procollagen III propeptide in patients with biopsy-proven nonalcoholic fatty liver disease.
    Kaya S; Boydak M; Aydin M; Aras İ
    Biotech Histochem; 2024 Aug; ():1-7. PubMed ID: 39092622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of waist circumference on insulin resistance and nonalcoholic fatty liver disease in apparently healthy Korean adults.
    Ju DY; Choe YG; Cho YK; Shin DS; Yoo SH; Yim SH; Lee JY; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI
    Clin Mol Hepatol; 2013 Jun; 19(2):140-7. PubMed ID: 23837138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum Level of Cytokeratin 18 (M65) as a Prognostic Marker of High Cardiovascular Disease Risk in Individuals with Non-Alcoholic Fatty Liver Disease.
    Pagano S; Bakker SJL; Juillard C; Dullaart RPF; Vuilleumier N
    Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study.
    Eguchi Y; Hyogo H; Ono M; Mizuta T; Ono N; Fujimoto K; Chayama K; Saibara T;
    J Gastroenterol; 2012 May; 47(5):586-95. PubMed ID: 22328022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caspase-cleaved fragments of cytokeratin-18 as a marker of inflammatory activity in chronic hepatitis B virus infection.
    Bae CB; Kim SS; Ahn SJ; Cho HJ; Kim SR; Park SY; Song GW; Kim DJ; Hwang SG; Yang JM; Kim YB; Park YN; Shin SJ; Cho SW; Cheong JY
    J Clin Virol; 2013 Dec; 58(4):641-6. PubMed ID: 24210327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease.
    Ergelen R; Akyuz U; Aydin Y; Eren F; Yilmaz Y
    Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):667-71. PubMed ID: 25923941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C.
    Parfieniuk-Kowerda A; Lapinski TW; Rogalska-Plonska M; Swiderska M; Panasiuk A; Jaroszewicz J; Flisiak R
    Liver Int; 2014 Apr; 34(4):544-50. PubMed ID: 23981197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poor Inter-test Reliability Between CK18 Kits as a Biomarker of NASH.
    Pimentel CF; Jiang ZG; Otsubo T; Feldbrügge L; Challies TL; Nasser I; Robson S; Afdhal N; Lai M
    Dig Dis Sci; 2016 Mar; 61(3):905-12. PubMed ID: 26462489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
    Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.